GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 89 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $393,000 | +82.8% | 16,433 | +11.3% | 0.00% | – |
Q4 2020 | $215,000 | +1.9% | 14,760 | -0.5% | 0.00% | – |
Q3 2020 | $211,000 | -18.8% | 14,836 | -15.9% | 0.00% | – |
Q2 2020 | $260,000 | +271.4% | 17,646 | +4.7% | 0.00% | – |
Q1 2020 | $70,000 | -27.1% | 16,860 | -15.5% | 0.00% | – |
Q4 2019 | $96,000 | -11.1% | 19,958 | +12.6% | 0.00% | – |
Q3 2019 | $108,000 | +22.7% | 17,721 | +31.4% | 0.00% | – |
Q2 2019 | $88,000 | +1.1% | 13,487 | +10.4% | 0.00% | – |
Q1 2019 | $87,000 | +58.2% | 12,213 | +8.0% | 0.00% | – |
Q4 2018 | $55,000 | -1.8% | 11,308 | +48.6% | 0.00% | – |
Q3 2018 | $56,000 | +14.3% | 7,608 | 0.0% | 0.00% | – |
Q2 2018 | $49,000 | -3.9% | 7,608 | -19.9% | 0.00% | – |
Q1 2018 | $51,000 | -7.3% | 9,500 | -26.7% | 0.00% | – |
Q4 2017 | $55,000 | -55.6% | 12,952 | 0.0% | 0.00% | – |
Q3 2017 | $124,000 | -9.5% | 12,952 | +12.4% | 0.00% | – |
Q2 2017 | $137,000 | -5.5% | 11,521 | +2.1% | 0.00% | – |
Q1 2017 | $145,000 | +2.8% | 11,281 | -1.3% | 0.00% | – |
Q4 2016 | $141,000 | +80.8% | 11,430 | +61.3% | 0.00% | – |
Q3 2016 | $78,000 | +13.0% | 7,087 | -12.8% | 0.00% | – |
Q2 2016 | $69,000 | +64.3% | 8,127 | 0.0% | 0.00% | – |
Q1 2016 | $42,000 | -32.3% | 8,127 | 0.0% | 0.00% | – |
Q4 2015 | $62,000 | 0.0% | 8,127 | 0.0% | 0.00% | – |
Q3 2015 | $62,000 | -17.3% | 8,127 | 0.0% | 0.00% | – |
Q2 2015 | $75,000 | -30.6% | 8,127 | 0.0% | 0.00% | – |
Q1 2015 | $108,000 | -4.4% | 8,127 | 0.0% | 0.00% | – |
Q4 2014 | $113,000 | +54.8% | 8,127 | 0.0% | 0.00% | – |
Q3 2014 | $73,000 | – | 8,127 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|